Skip to main content
    V

    Viatris Inc (VTRS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $20.74
    -0.08 (-0.38%)

    Market Cap: $23.87B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Viatris Inc (VTRS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Viatris (VTRS) to earn $2.59 per share in the fiscal year ending Dec 31, 2026, on revenue of $14.80B. Of 12 analysts, 7 rate the stock Buy or Strong Buy, 4 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 58% of the ratings.

    RatingAnalystsShare
    Strong Buy18.3%
    Buy650.0%
    Hold433.3%
    Sell00.0%
    Strong Sell18.3%
    Consensus
    Hold
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 5.4% and revenue estimates rise 2.8%.

    Fiscal year ending Dec 31, 2026
    $2.59
    EPS consensus, revenue $14.80B
    Fiscal year ending Dec 31, 2027
    $2.73
    EPS consensus, revenue $15.21B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.59$2.56 to $2.627$14.80B$14.73B to $14.93B9
    Dec 31, 2027$2.73$2.63 to $2.869$15.21B$14.95B to $15.32B7

    Quarterly Estimates

    The EPS consensus rises from $0.62 for the quarter ending Dec 31, 2026 to $0.63 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.62$0.56 to $0.6612$3.84B$3.64B to $3.99B11
    Mar 31, 2027$0.63$0.58 to $0.686$3.60B$3.53B to $3.67B5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 13 upward and 4 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202630
    Fiscal year ending Dec 31, 202772
    Quarter ending Mar 31, 202732

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.4% from $2.48.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.59$2.51$2.52$2.50$2.48+4.5%
    Fiscal year ending Dec 31, 2027$2.73$2.68$2.67$2.67$2.66+2.4%
    Quarter ending Mar 31, 2027$0.63$0.64$0.62$0.60$0.60+6.2%

    Frequently Asked Questions About VTRS

    What is the VTRS stock forecast?

    Consensus analyst estimates put Viatris's EPS at $2.59 for the fiscal year ending Dec 31, 2026, on revenue of $14.80B. The consensus rating from 12 analysts is Hold.

    How do analysts rate VTRS stock?

    Of 12 analysts covering Viatris, 1 rates it Strong Buy, 6 Buy, 4 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from VTRS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.59, with estimates from $2.56 to $2.62 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.73, with estimates from $2.63 to $2.86 from 9 analysts.

    What revenue do analysts expect from Viatris next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $14.80B, with estimates from $14.73B to $14.93B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $15.21B, with estimates from $14.95B to $15.32B.

    How many analysts cover VTRS?

    12 analysts rate Viatris stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.